Literature DB >> 28602429

Unusual Presentation of Foreign Body Granuloma of the Foot After Sharp Injury Mimicking a Malignant Lesion: A Case Report.

Narendran Pushpasekaran1, Manoharan Muthulingam2, Chandrasekaran Marimuthu3, Rajan Babu2, Naveen Kumar Rajapalani Kumar4.   

Abstract

Foot foreign body granulomas can mimic malignancies, especially when the history and unusual location pose a diagnostic dilemma. We report the case of a 33-year-old male with delayed-onset progressive swelling over the foot dorsum after a sharp injury through the plantar aspect of the foot. The unusual presentation and radiolucency warranted further radiologic evaluation, which revealed a benign foot swelling. An excision biopsy and histopathologic examination revealed a rubber body granuloma. No recurrence of the granuloma was noted during the 11-month follow-up period after removal of the offending agent. The nature of the injury, immunologic response to the rubber fragment, and lack of infection led to the delayed presentation at an unusual site, mimicking malignancy. Rubber body granuloma has rarely been reported in published studies. A high index of suspicion of retained radiolucent fragments and astute radiologic evaluation with magnetic resonance imaging are required for management of sharp injuries occurring through footwear. We reviewed the approach for evaluating such cases of foot swelling that can mimic malignancies.
Copyright © 2017 American College of Foot and Ankle Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  footwear; imaging; pseudoneoplasm; radiolucency; rubber

Mesh:

Year:  2017        PMID: 28602429     DOI: 10.1053/j.jfas.2017.04.033

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  1 in total

1.  Right ventricular outflow tract obstruction caused by a foreign body granuloma originating from a Dacron® graft 30 years after transannular patching.

Authors:  Woosik Han; Jae Hyeon Yu; Myung Hoon Na; Shinkwang Kang
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.